These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17996694)

  • 1. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.
    Kopf H; de la Rosa GM; Howard OM; Chen X
    Int Immunopharmacol; 2007 Dec; 7(13):1819-24. PubMed ID: 17996694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.
    Zhang W; Zhang D; Shen M; Liu Y; Tian Y; Thomson AW; Lee WP; Zheng XX
    J Immunol; 2010 Oct; 185(8):4750-9. PubMed ID: 20844194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
    Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
    Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].
    Zheng YX; Hou GH; Song J; Zhang C; Liang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):327-30. PubMed ID: 17428387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells.
    Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B
    Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation.
    Lu L; Qian XF; Rao JH; Wang XH; Zheng SG; Zhang F
    Transplant Proc; 2010 Jun; 42(5):1755-7. PubMed ID: 20620516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells.
    Zou H; He T; Chen X
    Int Immunopharmacol; 2019 Apr; 69():307-312. PubMed ID: 30769211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sirolimus-induced TGF-β secretion on mouse Treg cell proliferation.
    Li JN; Li JX; Huang HL; Zhu XL; Ding H; Huang CF; Lin J; Huang JG; Wu ZC; Ashraf M; Wang YG; Li XK; Zheng SY; Chen JM; Guo HM; Zhuang J; Zhu P
    Genet Mol Res; 2015 Dec; 14(4):18569-79. PubMed ID: 26782505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
    Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
    J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
    Skapenko A; Kalden JR; Lipsky PE; Schulze-Koops H
    J Immunol; 2005 Nov; 175(9):6107-16. PubMed ID: 16237107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
    Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS
    Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.